Related Experiment Video
Updated: Jun 17, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging
Kevin S Heffernan1, Christopher A Fahs, Sushant M Ranadive
1Division of Cardiology, Department of Medicine, The Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA. KHeffernan@TuftsMedicalCenter.org
Aging impairs blood vessel dilation, increasing cardiovascular disease risk. This review explores L-arginine supplementation as a nutritional strategy to combat age-related vascular dysfunction and improve endothelial function.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Nutritional Science
Background:
- Vascular senescence, characterized by impaired arterial dilation due to endothelial dysfunction, increases cardiovascular disease (CVD) risk with aging.
- L-arginine is an amino acid involved in critical physiological functions, with emerging evidence highlighting its role in vascular endothelial function.
Purpose of the Study:
- To review the potential of L-arginine as a nutritional intervention to mitigate vascular dysfunction associated with aging and CVD.
- To examine how L-arginine modulates vascular inflammation and systemic hormones to positively influence endothelial function.
Main Methods:
- Literature review focusing on studies investigating L-arginine's effects on vascular health in aging and CVD.
- Analysis of L-arginine's biochemical pathways and their impact on endothelial nitric oxide synthase (eNOS) activity.
- Examination of clinical and preclinical data on L-arginine supplementation and vascular outcomes.
Main Results:
- L-arginine supplementation may improve endothelial function by enhancing nitric oxide bioavailability.
- Modulation of inflammatory markers and hormonal balance by L-arginine shows promise in counteracting vascular senescence.
- Evidence suggests L-arginine can positively impact arterial dilation and reduce CVD risk factors.
Conclusions:
- L-arginine represents a potential nutritional strategy to address age-related vascular dysfunction and reduce CVD risk.
- Further research is warranted to establish optimal L-arginine dosages and long-term efficacy in diverse populations.
- Targeting endothelial function with L-arginine may offer a novel approach to promoting cardiovascular health during aging.
Related Concept Videos
Atherosclerosis III: Management
Pharmacodynamics in Geriatric Patients: Effects of Age
Antihypertensive Drugs: Vasodilators
Nitric Oxide Signaling Pathway
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

